Medicine
Invega 6 mg extended-release tablet
Invega 6 mg extended-release tablet is a prescription medicine containing Paliperidone for oral use, marketed by Janssen Pharmaceuticals, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store up to 25 °C (77 °F), excursions permitted to 15 °C to 30 °C (59 °F to 86…
Key facts
- Active ingredient (INN)
- Paliperidone
- Brand
- Invega
- Strength
- 6 mg
- Dosage form
- Extended-release tablet
- Route
- Oral
- Packs
- 30 tablets, 7 tablets
- Marketing authorisation holder
- Janssen Pharmaceuticals
- Manufacturer
- Janssen Pharmaceuticals
- Origin register
- US FDA, United States
- Storage
- Store up to 25 °C (77 °F), excursions permitted to 15 °C to 30 °C (59 °F to 86 °F). Protect from moisture.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- N05AX13 Paliperidone
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 19 December 2006
- Identifiers
- RxCUI 672567, 672569, 672571 +5DailyMed set ID 7b8e5b26-b9e4-4704-921b-3c3c0d159916NDC 50458-551Application NDA021999
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 30 tablet, extended release in 1 bottle | 50458-551-01 | Janssen Pharmaceuticals | 19 December 2006 |
| 7 tablet, extended release in 1 bottle | 50458-551-98 | Janssen Pharmaceuticals | 19 December 2006 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Paliperidone 6 mg extended-release tablet.
Other strengths and forms of Paliperidone
Clinical summary
Paliperidone is an atypical antipsychotic indicated for Treatment of schizophrenia, among other approved uses. It is available as extended-release tablets for oral use. MedsAcross supplies Paliperidone for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about PaliperidoneFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- INVEGA prescribing information (Janssen Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
- Byannli (previously Paliperidone Janssen-Cilag International): European public assessment report (EPAR) · European Medicines Agency
- Invega: European public assessment report (EPAR) · European Medicines Agency
Need Invega 6 mg extended-release tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.